FDA clears Cleveland Clinic 3D-printed airway stents | Medical Design and Outsourcing
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea
Related Articles
Radin Health Unveils Highly Anticipated All-In-One AI-Powered SaaS Solution Suite for Imaging Centers and Teleradiology Practices
/PRNewswire/ — Radin Health, a leading forward thinking MedTech company, announces the launch of its AI-powered All-In-One SaaS solution, designed to…
Elucid Receives U.S. 510(k) Clearance of PlaqueIQ™ Image Analysis Software to Aid Cardiovascular Disease Assessment – Elucid
First and Only Software Validated on Ground-Truth Histology, the Gold Standard for Plaque Characterization BOSTON, Oct. 1, 2024 – Elucid has announced it has received…
How A Physician Group Is Using AI to Save Clinicians 3+ Hours Per Day on Documentation – MedCity News
Alpine Physician Partners — which operates primary care organizations in several states — is implementing Ambience Healthcare’s documentation and coding tool after a successful pilot.…
Selling The New o1 ‘Strawberry’ to Healthcare Is a Crime, No Matter What OpenAI Says 🍓
4o is confidently misdiagnosing, while o1 is not only confidently misdiagnosing but also cleverly rationalizing the error.
Blue Shield of California inks deal to buy Humira biosimilar directly from manufacturer
A year ago, Blue Shield of California announced that it would move on from a traditional pharmacy benefit management relationship with CVS’ Caremark and instead…
At-home hospital care popular with patients and clinicians, but data backing quality, costs are limited, CMS finds
Hospital programs providing at-home acute care are widely appreciated by patients and clinicians but still don’t have a bulletproof argument in respect to quality and…
Eli Lilly Plans $4.5B Medicine Foundry to Foster Innovations in Drug Manufacturing – MedCity News
Lilly Medicine Foundry will research new ways to manufacture medicines. Eli Lilly says in addition to supporting the manufacturing of drugs for clinical trials, manufacturing…
SetPoint Medical gets FDA IDE to study neurostimulation for MS
SetPoint Medical received an FDA Investigational Device Exemption to study its implantable system for people with relapsing-remitting MS.
Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs – MedCity News
Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting…
Nym Rakes In $47M for Autonomous Coding Engine – MedCity News
Autonomous coding startup Nym raised $47 million. The New York City-based company has 21 provider customers, including Geisinger and Ochsner Health.